FDA, Drugmaker Investigating After Alzheimer's Patient Dies
Aduhelm, the Alzheimer’s drug approved this summer in a process that led some FDA advisers to quit , is the subject of new controversy. A 75-year-old woman in Canada participating...
Stay updated with breaking news from Medical Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Aduhelm, the Alzheimer’s drug approved this summer in a process that led some FDA advisers to quit , is the subject of new controversy. A 75-year-old woman in Canada participating...
According to the researchers the patient has a rare elite controller of the virus but has received no regular treatment for eight years and shows no signs of active infection or intact virus capable of replicating
Pregnancy puts patients at greater risk of dying of COVID, a new study shows. The death rate for the virus during pregnancy is three times greater than it would be otherwise,...
The study’s authors said they hope the result encourage more people to get the jab
The study highlighted that the age-wise mortality disruptions caused by the pandemic impacted more men than women.